Ads
related to: aafp asthma treatment guidelines- Home
Official Patient Website—
Get Treatment Info Today.
- Sign Up
Register Or Activate Your Card—
Find Out If You're Eligible Today.
- Getting Started
Learn More About Dosing Schedules
Find Answers To Your Questions
- Register For A Webinar
Learn From Medical Professionals
Hear From Real Patients Like You
- Home
Search results
Results From The WOW.Com Content Network
Exercise-induced bronchoconstriction. Exercise-induced bronchoconstriction (EIB) occurs when the airways narrow as a result of exercise. This condition has been referred to as exercise-induced asthma (EIA); however, this term is no longer preferred. [1] While exercise does not cause asthma, it is frequently an asthma trigger.
Acute severe asthma. Silent chest, worsening symptoms despite use of medication. [1] Acute severe asthma, also known as status asthmaticus, is an acute exacerbation of asthma that does not respond to standard treatments of bronchodilators (inhalers) and corticosteroids. [2] Asthma is caused by multiple genes, some having protective effect, with ...
Aspirin-exacerbated respiratory disease (AERD), also called NSAID-exacerbated respiratory disease (N-ERD) or historically aspirin-induced asthma and Samter's Triad, is a long-term disease defined by three simultaneous symptoms: asthma, chronic rhinosinusitis with nasal polyps, and intolerance of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs).
Wednesday, Sanofi SA (NASDAQ:SNY) reported results from the Phase 2 study of oral rilzabrutinib in adult patients with uncontrolled moderate-to-severe asthma. Two doses of rilzabrutinib, 800 mg ...
Treatment. corticosteroids. Eosinophilic bronchitis (EB) is a type of airway inflammation due to excessive mast cell recruitment and activation in the superficial airways as opposed to the smooth muscles of the airways as seen in asthma. [1][2] It often results in a chronic cough. [1] Lung function tests are usually normal. [1]
Long-acting β adrenoceptor agonists (LABAs) are beta-adrenergic agonists usually prescribed for moderate-to-severe persistent asthma and chronic obstructive pulmonary disease (COPD). LABAs are designed to reduce the need for shorter-acting β 2 agonists such as salbutamol (albuterol), as they have an approximately twelve-hour duration of ...
Ads
related to: aafp asthma treatment guidelines